Primary care
A primary-care clinician may assess and prescribe oral naltrexone. Tests, referral, and timing depend on recent opioids, health history, and local practice; same-day treatment should not be assumed.
United States
Generic oral tablets and monthly Vivitrol follow different prescribing, billing, and administration routes. The useful insurance question names the product, diagnosis, benefit type, prior authorisation, and site-of-care fee.

US patients may encounter oral naltrexone tablets (commonly 50 mg generics) or Vivitrol, a 380 mg extended-release injection administered by a healthcare professional.
Coverage depends on the exact plan and whether a product is billed through a pharmacy or medical benefit. A formulary listing is not the same as zero out-of-pocket cost; prior authorization, site-of-care rules, deductibles, and eligibility for assistance can all matter.
The current FDA Vivitrol label was revised in December 2025. It tells clinicians to discuss and strongly consider prescribing an opioid-overdose reversal agent, while emphasizing the risks of precipitated withdrawal, attempts to overcome blockade, and overdose after treatment is interrupted or stopped.
Availability and cost depend on the provider as well as the product.
A primary-care clinician may assess and prescribe oral naltrexone. Tests, referral, and timing depend on recent opioids, health history, and local practice; same-day treatment should not be assumed.
A specialist or substance-use service may help when the history is complex or when a monthly injection is being considered.
Programme services, medicines, counselling, grant support, and eligibility vary. Ask whether oral naltrexone and Vivitrol are actually offered before travelling.
State rules and provider policies change. Even when assessment occurs remotely, Vivitrol still requires in-person administration and oral pharmacy stock needs checking.
Do not rely on national coverage percentages for an individual claim.
Check the current formulary, prior authorization, deductible, site-of-care rule, and whether Vivitrol is billed under the medical or pharmacy benefit. Manufacturer assistance has eligibility and savings limits.
Rules are state-specific. Ask the state plan or managed-care plan about the exact NDC/J-code, indication, prior authorization, preferred alternatives, and administration fee.
Coverage may involve Part D or a medical benefit depending on product and setting. Manufacturer copay cards generally exclude federal health-program beneficiaries; verify with the plan.
Request separate written prices for medicine, clinician visit, laboratory work, and injection administration. Ask federally qualified health centers and official patient-assistance programs about eligibility.

Product and label facts checked 26 July 2026.
Initial US approval for opioid dependence
Oral naltrexone approval expanded to alcohol dependence
Extended-release intramuscular injection every 4 weeks
FDA label date for Vivitrol safety information
For alcohol dependence, patients should not be actively drinking at the first injection. For opioid dependence, the label recommends an adequate opioid-free interval. A urine test or naloxone challenge may inform assessment but does not guarantee that precipitated withdrawal cannot occur.
Coverage is plan- and product-specific. Ask about the oral naltrexone product, diagnosis, quantity, and prior authorisation rather than assuming the plan covers or excludes a named dosing method.
The FDA approved an abbreviated application in 2023. Approval alone does not prove current marketing or local supply; ask the provider and check the live FDA product record.
Eligible veterans can ask their VA clinician about oral or extended-release naltrexone. Individual eligibility, clinical suitability, local availability, and copay rules still need confirmation.
A tablet creates a recurring at-home routine. Vivitrol removes the daily tablet decision but adds monthly appointments, injection-site monitoring, and a different billing pathway.
State law, clinician licensing, provider policy, and the required assessment all matter. Oral treatment may sometimes begin remotely; Vivitrol administration is in person.
Use SAMHSA's directory to find care. Before agreeing to a product, ask the plan and provider about medicine cost, administration, laboratory work, prior authorisation, and any assistance restrictions.
Content and sources reviewed